NEPHROCARE

Nephro Care India Limited

Listed company · ISIN INE0SUN01013 · NSE SM · FV ₹10
Last price
₹90
-1.10%today
What this company does

Nephro Care India Limited is a listed company. It booked ₹29 cr of revenue in its latest quarter (Q1 FY27) and kept 5.5% of sales as profit.

65out of 100
Equitytale Health Score
Solid

Healthier than 65% of listed companies we score, on the 5 of 6 measures we could read for it. Each measure is ranked against the 2,463–2,885 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
50

At close. Not part of the score.

Profitability & returns59

How much profit it earns on the money it employs

Balance sheet90

How much it owes, and whether earnings cover the interest

Cash quality43

Whether reported profit actually arrives as cash

Valuation42

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
A mixed picture
Strengths
✓ Makes a profit
✓ Promoters hold 62%
✓ No promoter shares pledged
✓ Strong 16% return on equity
✓ Virtually debt-free
Watch-outs
! Thin 5.5% net margin

What if I invest in NEPHROCARE?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹90▼ -1.10%
latest close · 2026-10-01
52-wk low ₹6052 sessions so far52-wk high ₹108
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio22.9Average
LowAverageHigh
P/B ratio3.66High
Below bookModerateHigh
EV / EBITDA13.4Average
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity15.9%Strong
WeakFairStrong ▸15%
Return on capital18.4%Strong
WeakFairStrong
Net margin5.5%Decent
ThinDecentStrong
EBITDA margin9.1%Thin
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.00Comfortable
LowModerateHigh ▸1
Interest cover76.5×Strong
RiskyOkayStrong ▸5×
Current ratio2.02Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹148 cr
Book value
₹24
EPS
₹0.98
latest quarter
Net debt
₹-6 cr
more cash than debt
Enterprise value
₹141 cr
EBITDA
₹11 cr
annualised
EBIT
₹11 cr
annualised
Operating margin
9.1%
Return on assets
8.8%
Earnings yield
4.37%
P/S
1.27
Sales / share
₹70.8
Tax rate
38.4%
Face value
₹10
Shares
1.6 cr
Working capital
₹16 cr
Current assets
₹31 cr
Current liabilities
₹15 cr
Delivery %
69.3%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-10-01.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
Too few reliable models — the filings don't support two independent estimates of value.
Models span ₹11–₹11, midpoint ₹11

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹29 cr
Other Income₹22.3 L
Total Income₹29 cr
Cost of Materials₹0 cr
Purchases of Stock-in-Trade₹10 cr
Inventory Change (±)₹-76.8 L
Employee Benefit Expense₹4 cr
Finance Costs₹3.5 L
Other Expenses₹13 cr
Total Expenses₹27 cr
Profit before Tax₹3 cr
Tax Expense₹1 cr
Net Profit₹2 cr
Net margin on total income5.5%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹9 cr30.6%
Employee benefit expense₹4 cr13.7%
Finance costs₹3.5 L0.1%
Other expenses₹14 cr46.7%
Tax expense₹1 cr3.4%
Profit for the period₹2 cr5.5%
Total income ₹29 cradds up to ₹100 ✓
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹73 cr
Shareholder equity
₹40 cr
parent shareholders
Total debt
₹0 cr
Cash
₹6 cr
Who owns it · 2026-06-30
No pledge
Promoter
61.7%
FII / Foreign
1.0%
DII / Domestic
1.3%
Retail / others
36.0%
Promoter stake up 0.3% over the last 4 quarters.
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 25 Sep 2026
See the official result
1
To consider and adopt the audited Standalone & Consolidated financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon;
Backed by 100% of shareholders other than promotersneeded 50%
2.22 L votes for, 0 against
2
Dr. Pritam Sengupta (DIN: 06795012) will retire by rotation and being eligible will be re-appointed as Director.
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
2.22 L votes for, 800 against
3
Dr. Sutapa Sen (DIN: 08672795) will retire by rotation and being eligible will be re-appointed as Director.
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
2.22 L votes for, 0 against

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 4 named members
owning 61.7% between them · as of 2026-06-30
PRATIM SENGUPTA60.98%
PRADYOT KUMAR SENGUPTA0.29%
SHILA SENGUPTA0.29%
PRASENJIT SENGUPTA0.15%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.